Evidence map›Paper›PMID 32149011›Full record

ReviewKidney international supplements2020

Developing the ethical framework of end-stage kidney disease care: from practice to policy.

Valerie A Luyckx, Dominique E Martin, Mohammed Rafique Moosa, Aminu K Bello, Ezequiel Bellorin-Font, Tak Mao Chan, Rolando Claure-Del Granado, Walter Douthat, Somchai Eiam-Ong, Felicia U Eke and 11 more

Abstract readReview
In one paragraph

Review in Kidney international supplements, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
  3. Review
  4. Review
  5. Review
  6. The current and future landscape of dialysis.Nature reviews. Nephrology · 2020
    Review
  7. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

21 authors.

Valerie A LuyckxInstitute of Biomedical Ethics and the History of Medicine, University of Zurich, Zurich, Switzerland.
Dominique E MartinSchool of Medicine, Deakin University, Melbourne, Victoria, Australia.
Mohammed Rafique MoosaDivision of Nephrology, Department of Medicine, Faculty of Medicine and Health Sciences, Stellenbosch University and Tygerberg Academic Hospital, Cape Town, South Africa.
Aminu K BelloDivision of Nephrology and Immunity, Department of Medicine, University of Alberta, Edmonton, Alberta, Canada.
Ezequiel Bellorin-FontDivision of Nephrology and Hypertension, Department of Medicine, Saint Louis University, Saint Louis, Missouri, USA.
Tak Mao ChanDivision of Nephrology, Department of Medicine, University of Hong Kong, Hong Kong.
Rolando Claure-Del GranadoDivision of Nephrology, Department of Medicine, Hospital Obrero 2-Caja Nacional de Salud, Universidad Mayor de San Simon School of Medicine, Cochabamba, Bolivia.
Walter DouthatHospital Privado-Universitario de Cordoba and Instituto Universitario de Ciencias Biomédicas, Cordoba, Argentina.
Somchai Eiam-OngDepartment of Medicine, Chulalongkorn Hospital, Bangkok, Thailand.
Felicia U EkeDepartment of Pediatrics, University of Port Harcourt Teaching Hospital, Port Harcourt, Nigeria.
Bak Leong GohDepartment of Nephrology and Clinical Research Centre, Hospital Serdang, Jalan Puchong, Kajang, Selangor, Malaysia.
Vivekanand JhaGeorge Institute for Global Health India, New Delhi, India.
Evie KendalSchool of Medicine, Deakin University, Melbourne, Victoria, Australia.
Adrian LiewDepartment of Renal Medicine, Tan Tock Seng Hospital, Singapore.
Yewondwossen Tadesse MengistuSchool of Medicine, Addis Ababa University, Addis Ababa, Ethiopia.
Elmi MullerTransplant Unit, Department of Surgery, Groote Schuur Hospital, University of Cape Town, Cape Town, South Africa.
Ikechi G OkpechiDivision of Nephrology and Hypertension, University of Cape Town, Cape Town, South Africa.
Eric RondeauIntensive Care Nephrology and Transplantation Department, Hopital Tenon, Assistance Publique-Hôpitaux de Paris, Paris, France.
Manisha SahayDepartment of Nephrology, Osmania Medical College and General Hospital, Hyderabad, Telangana, India.
Michele TraskSchool of Nursing, University of British Columbia, Vancouver, British Columbia, Canada.
Tushar VachharajaniNephrology Section, Salisbury Veterans Affairs Health Care System, Salisbury, North Carolina, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Ethical issues relating to end-stage kidney disease (ESKD) care are increasingly being discussed by clinicians and ethicists but are still infrequently considered at a policy level or in the education and training of health care professionals. In most lower-income countries, access to kidney replacement therapies such as dialysis is not universal, leading to overt or implicit rationing of resources and potential exclusion from care of those who are unable to sustain out-of-pocket payments. These circumstances create significant inequities in access to ESKD care within and between countries and impose emotional and moral burdens on patients, families, and health care workers involved in decision-making and provision of care. End-of-life decision-making in the context of ESKD care in all countries may also create ethical dilemmas for policy makers, professionals, patients, and their families. This review outlines several ethical implications of the complex challenges that arise in the management of ESKD care around the world. We argue that more work is required to develop the ethics of ESKD care, so as to provide ethical guidance in decision-making and education and training for professionals that will support ethical practice in delivery of ESKD care. We briefly review steps that may be required to accomplish this goal, discussing potential barriers and strategies for success.

Indexed as

dialysisend-stage kidney diseaseESKDethics

Identifiers

PMID32149011
PMCPMC7031685

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.